glp 1 weight loss medicine GLP-1 Drugs from the Gray Market Another Weight-Loss Trial Win for

Important observations All five clinical trials that were included in the analysis reported GLP-1 receptor agonist-mediated reduction in substance use disorder, with two trials respectively reporting a significant therapeutic impact of GLP-1 receptor agonist in reducing alcohol use disorder and nicotine use disorder

Initial data were promising, suggesting it could induce 1012% weight loss as monotherapy (though not as high as GLP-1s)

They help with weight loss by reducing ones appetite and increasing the feeling of being full, slowing digestion, and reducing what some refer to as food noise. GLP-1s are a valuable, proven tool when part of a weight-management program that includes lifestyle changes such as healthier eating and increased activity

Jeff Livingston Main Blog Photo By: Pixelshot

Current litigation involving GLP-1 medications focuses primarily on severe gastrointestinal injuries, including gastroparesis, ileus, and intestinal obstruction, as well as emerging reports of possible vision loss in certain patients